Expression of protective protein in human tissue

Pediatric Neurology

Volumn 20, Issue 3, 1999, Pages 210-214

  Sohma, Osamu ^a   Mizuguchi, Masashi ^a   Takashima, Sachio ^a   Satake, Akira ^b   Itoh, Kohji ^b   Sakuraba, Hitoshi ^b   Suzuki, Yoshiyuki ^b   Oyanagi, Kiyomitsu ^c  

^a Dept Mental Retard Birth Defect R ^*  (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c Ctr Mat Brain Dis Brain R   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CELL SPECIFICITY; DISULFIDE BOND; ENZYME ACTIVITY; ENZYME STABILITY; EPITHELIUM CELL; GALACTOSIALIDOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING;

EID: 0032947156     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(98)00151-9     Document Type: Article

References (22)

1. d'Azzo A., Hoogeveen A., Reuser J.J., Robinson D., Galjaard H. Molecular defect in combined β-galactosidase and neuramidase deficiency in man. Proc Natl Acad Sci U S A. 79:1982;4535-4539.
2. Jackman H., Tan F., Tamei H., et al. A peptidase in human platelets that deamidates tachykinins Probable identity with the lysosomal "protective protein . " J Biol Chem. 265:1990;11265-11272.
3. Jackman H., Morris P.W., Deddish P.A., Skidgel R.A., Erdos E.G. Inactivation of endothelin I by deamidase (lysosomal protective protein). J Biol Chem. 267:1992;2872-2875.
4. Kase R., Itoh K., Takiyama N., Oshima A., Sakuraba H., Suzuki Y. Galactosialidosis Simultaneous deficiency of esterase, carboxy-terminal deamidase and acid carboxypeptidase activities . Biochem Biophys Res Commun. 172:1990;1175-1179.
5. Galjart N.J., Gillemans N., Harris A., et al. Expression of cDNA encoding the human "protective protein" associated with lysosomal β-galactosidase and neuramidase Homology to yeast proteases . Cell. 54:1988;755-764.
6. Itoh K., Taiyama N., Kase R., et al. Purification and characterization of human lysosomal protective protein expressed in stably transformed Chinese hamster ovary cells. J Biol Chem. 268:1993;1180-1186.
7. Satake A., Itoh K., Shimoto M., Saido T., Sakuraba H., Suzuki Y. Distribution of lysosomal protective protein in human tissues. Biochem Biophys Res Commun. 205:1994;38-43.
8. Shimoto M., Fukuhara Y., Itoh K., Oshima A., Sakuraba H., Suzuki Y. Protective protein gene mutations in galactosialidosis. J Clin Invest. 91:1993;2393-2398.
9. Takano T., Shimmoto M., Fukuhara Y., et al. Galactosialidosis Clinical and molecular analysis of 19 Japanese patients . Brain Dysfunct. 4:1991;271-280.
10. Oyanagi K., Ohama E., Miyashita K., et al. Galactosialidosis Neuropathological findings in a case of the late infantile type . Acta Neuropathol (Berl). 82:1991;331-339.
11. Lerner R.A., Green N., Alexander H., Liu F., Sutcliffe J.G., Shinnick T.M. Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc Natl Acad Sci U S A. 78:1981;3403-3407.
12. Potier M., Michaux L., Tranchmontagne J., Thauvette E. Structure of the lysosomal neuramidase-β-galactosidase-carboxylpeptidase multienzymic complex. Biochem J. 267:1990;197-202.
13. Galjart N.J., Morreau H., Willemsen R., Gillemans N., Bonten E.J., d'Azzo A. Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function. J Biol Chem. 266:1991;14754-14762.
14. Galjart N.J., Gillemans N., Meijer D., d'Azzo A. Mouse "protective protein. " J Biol Chem. 265:1990;4678-4684.
15. Amano N., Yokoi S., Akagi M., Sakai M., Yagishita S., Nakata K. Neuropathologic findings of an autopsy case of adult β-galactosidase and neuramidase deficiency. Acta Neuropathol (Berl). 61:1983;283-290.
16. Kyllerman M., Mansson J.E., Westphal O., Conradi N., Nellstrom H. Infantile galactosialidosis presenting with congenital adrenal hyperplasia and renal hypertension. Pediatr Neurol. 9:1993;318-322.
17. Miyatake T., Atsumi T., Obayashi T., et al. Adult type neuronal storage disease with neuramidase deficiency. Ann Neurol. 6:1978;232-244.
18. Okada S., Sugino H., Kato T., et al. A severe infantile sialidosis (β-galactosidase-α-neuramidase deficiency) mimicking GM1-galactosialidosis type. Eur J Pediatr. 140:1983;295-298.
19. Sakuraba H., Suzuki Y., Akagi M., Sakai M., Amano N. β-Galactosidase-neuramidase deficiency (galactosialidosis) Clinical, pathological, and enzymatic studies in a postmortem case . Ann Neurol. 13:1983;497-503.
20. Yamano T., Shimada M. Ultrastructural study on a severe infantile sialidosis (β-galactosidase-α-neuramidase deficiency). Neuropediatrics. 16:1985;109-112.
21. Yoshino H., Miyashita K., Miyatani N., et al. Abnormal glycosphingolipid metabolism in the nervous system of galactosialidosis. J Neurol Sci. 97:1990;53-65.
22. Palmeri S., Hoogeveen A., Verheijen F.W., Galjaard H. Galactosialidosis Molecular heterogeneity among distinct clinical phenotypes . Am J Hum Genet. 38:1986;137-148.